Related Experiment Video
Updated: Feb 2, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Targeted Therapy of Melanoma
1Department of Dermatology and Allergy, University Hospital Munich (LMU), Munich, Germany.
Abstract:
In recent years, the treatment of advanced melanoma has been revolutionized by the introduction of new innovative approaches, namely mutation-based targeted therapy and immune checkpoint blockade by CTLA4 and PD-1/PD-L1 inhibitors. The decade-long era of chemotherapy with very low response rates of 5-20% and short median survival rates of 6-9 months has been left in favor of new therapies with response rates ranging between 40% and 70% and median overall survival rates of 2 years and longer (Heppt et al., 2015, Larkin et al., 2014, Long et al., 2015, Long et al., 2016, Schadendorf et al., 2015).
Insights
New targeted therapies and immune checkpoint inhibitors have transformed advanced melanoma treatment. These innovative approaches offer significantly higher response rates and longer survival compared to traditional chemotherapy.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Advanced melanoma treatment historically relied on chemotherapy with limited efficacy.
- Chemotherapy for advanced melanoma showed response rates of 5-20% and median survival of 6-9 months.
Purpose of the Study:
- To highlight the revolutionary impact of novel treatment modalities in advanced melanoma.
- To compare the outcomes of targeted therapy and immune checkpoint blockade with previous chemotherapy regimens.
Main Methods:
- Review of recent advancements in melanoma treatment.
- Comparison of response rates and survival data between new therapies and chemotherapy.
Main Results:
- Mutation-based targeted therapy and immune checkpoint inhibitors (CTLA4, PD-1/PD-L1) have revolutionized treatment.
- New therapies demonstrate response rates of 40-70% and median overall survival exceeding 2 years.
- These outcomes represent a significant improvement over traditional chemotherapy.
Conclusions:
- Targeted therapy and immune checkpoint blockade are superior to chemotherapy for advanced melanoma.
- These innovative treatments offer improved patient outcomes and survival benefits.
- The treatment landscape for advanced melanoma has fundamentally shifted towards personalized and immune-based strategies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Group Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications

